Professor Miriam Johnson Miriam.Johnson@hull.ac.uk
Professor
HIDDEN: Hospice Inpatient Deep vein thrombosis detection study
People Involved
Project Description
Between four and 20% of cancer patients will develop venous thromboembolism (VTE) during their illness but the true number is unknown as patients may be asymptomatic. Furthermore, we do not know whether apparently “silent” deep vein thromboses (DVTs), if untreated, will progress to cause swollen, painful legs, or a clot to the lung (pulmonary embolus [PE]) possibly resulting in chest pain, breathlessness, collapse or death, or whether the clots would resolve by themselves. There are UK treatment guidelines to prevent VTE in cancer patients admitted to hospital. However, we do not know whether these should apply to advanced cancer patients admitted to specialist palliative care units (SPCU) such as hospices, as there is some evidence to suggest that there is no survival benefit in this group. Furthermore, we do not know whether treatment to prevent VTE improves symptom control and quality of life, or if benefit outweighs the risk of treatment (e.g. bleeding) in these patients. Therefore, it is important to discover the proportion of cancer patients in SPCUs with a VTE and the impact this has so we know how we should manage people with advanced cancer.
The aim of the HIDDen study is to identify the proportion of cancer patients admitted to SPCUs who have a VTE. A Doppler scanner will be used to scan patients’ legs to determine whether they have a DVT, and then they will be followed up to see what happens to them. A Doppler scanner is easy to use, cheaper than other methods and can be used at the hospice bedside. Consecutive admissions to SPCUs in England (one site), Northern Ireland (three sites) and Wales (one site) will be recruited into the study until 217 cancer patients are accrued. The results of this study will inform clinical guidelines on VTE prevention in SPCUs.
Project Acronym | HIDDen |
---|---|
Status | Project Complete |
Value | £112,940.00 |
Project Dates | May 27, 2016 - Dec 31, 2019 |
You might also like
FRAIL-HEART: Assessment of Frailty in Elderly People with Ischemic Heart Disease being considered for Revascularisation: An Observational study Apr 1, 2017 - Mar 31, 2020
To summarise the study, we will recruit patients aged 80 years or more who attend the cardiology and cardio-thoracic departments of Castle Hill Hospital, Hull and who have been given a diagnosis of coronary artery disease. The patients will be identi...
Read More about FRAIL-HEART: Assessment of Frailty in Elderly People with Ischemic Heart Disease being considered for Revascularisation: An Observational study.
BREATHE: Breathlessness RElief AT HomE Apr 1, 2019 - Oct 31, 2021
A feasibility study to address this RQ:
Does a paramedic-administered short non-pharmacological complex breathlessness intervention improve breathlessness and reduce conveyance to ED for people with breathlessness crisis compared with usual practice...
Read More about BREATHE: Breathlessness RElief AT HomE.
RESOLVE: Improving Health Status and Experience of Pain and other Symptoms for People with Advanced Cancer Jun 1, 2018 - Jan 28, 2024
In Yorkshire, over 14,000 people die from advanced cancer each year, a number expected to rise to 17,000 yearly by 2030. In the weeks or months before they die, people with advanced cancer often experience pain, breathlessness or fatigue-exhaustion,...
Read More about RESOLVE: Improving Health Status and Experience of Pain and other Symptoms for People with Advanced Cancer.
RAMBO: Research Assessment Outcome Measures for Malignant Bowel Obstruction Jul 1, 2019 - Nov 30, 2021
Malignant bowel obstruction (MBO) is a common problem faced by patients with advanced cancer of the ovaries and bowel. It occurs when the cancer causes a blockage or blockages in the intestines. The symptoms are very distressing for patients and thei...
Read More about RAMBO: Research Assessment Outcome Measures for Malignant Bowel Obstruction.